Chelating agents such as
calcium disodium ethylenediaminetetraacetate (
EDTA),
2,3-dimercaptopropanol (BAL), or
D-penicillamine (D-PA) have been widely used for the past 4 decades as antidotes for the treatment of acute and chronic
metal poisoning. In recent years, meso-2,3-dimercaptosuccinic
acid (
DMSA),
sodium 2,3-dimercapto-1-propanesulfonate (
DMPS) and
sodium 4,5-dihydroxybenzene-1,3-disulfonate (
Tiron) have also shown to be effective to prevent against toxicity induced by a number of
heavy metals. The purpose of the present article was to review the protective activity of various
chelating agents against the embryotoxic and teratogenic effects of well-known developmental toxicants (
arsenic,
cadmium, lead,
mercury,
uranium, and
vanadium).
DMSA and
DMPS were found to be effective in alleviating
arsenate- and
arsenite-induced
teratogenesis, whereas BAL afforded only some protection against
arsenic-induced embryo/fetal toxicity. Also,
DMSA,
DMPS, and
Tiopronin were effective in ameliorating methyl
mercury-induced developmental toxicity. Although the embryotoxic and teratogenic effects of
vanadate were significantly reduced by
Tiron, no significant amelioration of
uranium-induced embryotoxicity was observed
after treatment with this
chelator.